Biopharma Leadership Conclave 2021 - Day 2: Protein Biotherapeutics: Overview, CQA & Impurity Analysis, Glycans, QC and Process Analytics

You will be updated on latest technological launches, analytical challenges & workflow solutions & latest applications through live talks, panel discussions from industries experts & Agilent Biopharma specialists.

2:45 PM (IST) Overview of Biopharmaceuticals and CQA Analysis

• Dr. Venkata R Yeturu (Vice President, CuraTeQ Biologics)

3:10 PM (IST) Process Related Impurities In Biologics Manufacturing

• Dr. Dhananjay Patankar (Biopharma Professional & Independent Consultant)

3:30 PM (IST) Bridging the Gap : Agilent Solutions

• Dr. Ashish Pargaonkar (Manager, Center of Excellence, Agilent Technologies)

3:40 PM (IST) Workflows for Released N-Glycan Analysis and Sialic Acid Quantitation of Biotherapeutics

• Marco Rhotert (Technical Support Specialist, Agilent Technologies UK)

3:50 PM (IST) Process Analytical Technology (PAT) and Implementation in Biologics Manufacturing

• Dr. Rajendar Burki (Associate Vice President, Research and Development, Biological E. Limited)

4:15 PM (IST) Multi-Attribute Methods (MAM) for the Characterization of Biopharmaceuticals

• Dr. Annu Uppal (Associate Director - Scientific Affairs, USP-India)

4:30 PM (IST) Agilent Bio LC solutions for Development, Biologic Manufacturing & QA/QC

• Ms. Paramjeet Khandpur (Agilent Technologies)

4:45 PM (IST) Panel Discussion

• Moderated by Dr. Vadi Bhat and Mr. Chirag Khambhati